Full title: SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Age: Cohort 1: 12-29, Cohort 2: 12+
Patient’s data and biological samples (such as tumour and blood samples) will be collected and analysed. The samples and information will be used to find tumour characteristics or changes to support future research that may help patients now and in the future. The aim is that patients who participate could be offered access to drugs/treatments that specifically target the characteristics of their tumour, in particular within clinical trials.